Cian Healthcare subsidiary equity extinguished

Cian Healthcare Limited announced that its wholly owned subsidiary, Dr. Smiths Biotech Private Limited, has had its entire existing equity share capital extinguished and cancelled. This action follows the approval of a resolution plan by Ananta Medicare Limited under the Corporate Insolvency Resolution Process (CIRP) initiated by Small Industries Development Bank of India. The NCLT approved the plan on September 23, 2026, with the cancellation effective October 23, 2026. Dr. Smith ceased to be a subsidiary of Cian Healthcare from that date. For FY 2025-26, Dr. Smith contributed NIL revenue from operations and ₹1.03 lakhs in total income (0.03% of consolidated income), with a negative net worth of ₹(987.00) lakhs (115.63% of consolidated net worth). No consideration was received by Cian Healthcare.